-
-
-
-
-
-
-
RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia®
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer
-
-
-
-
-
-
-
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
-
-
-
-
-
-
-
RedHill Biopharma's (RDHL) RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Provides H1'22 Highlights and Q3 Estimates
-
-
-
-
-
-
-
RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia® for the United Arab Emirates
-
-
-
-
-
-
-
RedHill Biopharma Announces New U.S. Patent Covering Talicia for H. pylori Infection Through 2034
-
68,109 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

